Get started
Vaxart, Inc. - Common StockVaxart, Inc. - Common StockVaxart, Inc. - Common Stock

Vaxart, Inc. - Common Stock

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Options Bonds

VXRT trade ideas

Wait Until the $15+ Wave: Reiterating LongAgain, I think this is one of the more decent speculative plays or dip opportunities for a swing out there. Shorts are soon going to need to likely cover, you have an RSI less than 30, and people are overreacting to the clinical data and news headlines. The support level just needs to pickup for a really good squeeze. PR could come like a hammer for overly anxious bears. That said, please invest at your own risk and do your own due diligence. Everything I say is on an opinion based basis.
NASDAQ:VXRTLong
by gamer456148
$VXRT speculative play after the 60% dropHello dear padawans. I hope everybody is doing well. If you don't know VAXART, they are working on a covid vaccine that is taken orally; apparently the only one in the US (world?). The stock fell today after the first phase of tests yield no antibody response on volunteers (more here: cnb.cx). They are continuing their research into a phase two so this is not all done for their vaccine yet. As you know, when these things happen investors overreact and the chain effect drives the price down; perhaps exaggeratedly in many cases. This may be one of those so we can use that in our favor. I am using the 1hr timeframe here because it seems the action responded to the fib levels in the 1hr chart more closely than other indicators on the 4hr and daily charts. As you can see, the 0 level was tested twice and the price reacted by moving up. You can also see that that level was support for 6 days before the price spiked up so it seems it is a strong level. Other indicators are obviously turning bearish really quickly after that huge fall so they don't help us much here. Even though the price bounced twice from that level it could still move back down since investors may still be deciding what to do from here. Also keep in mind this is the 1hr timeframe so it is normal to see these 10% intraday swings. I may start a trade tomorrow if I can use one of those fib levels to anchor my entry. If it breaks below the 0 fib level the next support is the 50ema on the daily, around $8.5 but at the time of this writing, but I think it would most likely go down to around the $6.9 support and rest there. I did a similar play on FOSSIL after the drop last week and cashed an easy 40% in a day. Maybe this one will pan out as well. Safe trades! Show your love: If you get anything out of this TA, please hit the like button so other can find this analysis quicker. Follow for more: If you want the best entry/exits just follow me, you won't regret. Thanks a lot! ***The ideas shared here are my opinion, not financial advise to place trades. Please do your own research before buying/selling stocks***
NASDAQ:VXRT
by Safe_Trades
7
VXRT Breakout Stock Alert UpdateBREAKOUT STOCK ALERT UPDATE $VXRT - Vaxart, Inc. - Common Stock Initial Alert Price: $6.8 Price High: $12.74 % Gains/Losses: 87.35% (+66.85% More Than Expected) Potential Stop Loss: $12.103 VXRT is currently down 58.85% in today's trading session after reporting that neutralizing antibodies were not detected in volunteers after a single dose of its experimental oral COVID-19 vaccine candidate, VXA-CoV2-1, in a Phase 1 trial of 35 healthy adults. Researchers believe the antibodies play an important role in defending cells against the virus. This was the worse plunge for the stock since November 2012 and fortunately we updated everyone yesterday with concerns of consolidation and pullbacks but not to this extent. #Breakout #Stocks #Trading #Investing #Alerts #StockMarket #Daily #News #Today
NASDAQ:VXRTLong
by MyMIWallet
VXRT Breakout Stock Alert UpdateBREAKOUT STOCK ALERT UPDATE $VXRT - Vaxart, Inc. - Common Stock Initial Alert Price: $6.8 Price High: $24.9 % Gains/Losses: 266.18% (+245.85% More Than Expected) Potential Stop Loss: $23.655 Wanted to give an update on VXRT after the stock provided us with a 266.18% Gain on our initial trade alert on Jan. 14th and up another 100% from yesterday's trade alert update. Yesterday we were looking to see if the stock could breakthrough the $17.49 Levels of Resistance, so now we're to see if that will be come our future support or will it breakthrough those levels from a heavier sell-off from profit-taking and simple consolidation. Definitely something to keep an eye on going into tomorrow as the stock is still showing movement to the upside although we could see a potential gap down in tomorrow's pre-market session or market open. We would suggest watching how the stock opens tomorrow to determine our further outlook on the trade. #Breakout #Stocks #Trading #Investing #Alerts #StockMarket #Daily #News #Today
NASDAQ:VXRTLong
by MyMIWallet
3
VXRT Breakout Stock Alert UpdateBREAKOUT STOCK ALERT UPDATE $VXRT - Vaxart, Inc. - Common Stock Initial Alert Price: $6.8 Price High: $15.8 % Gains/Losses: 132.35% (+111.85% More Than Expected) Potential Stop Loss: $15.01 VXRT hit $15.80 at it's high in today's trading session on pure moment as there has not been any press releases disclosing any news to explain the price action. This is our 2nd 100%+ Gainer of the Day, providing a 120% return on our initial trade alert from Jan. 14th, 2021. The stock found strong resistance at those $15.80 Price Levels and is currently show signs of consolidation, if not a pullback although, so we suggest preparing for profit taking here moving to protect your own profits. New Term: Split and Run Moving forward, when we refer to a Split and Run, we are referring to selling half of positions to lock in profits by protecting the initial investment into a stock while allowing the profits to continue to accumulate more profits on its own. #Breakout #Stocks #Trading #Investing #Alerts #StockMarket #Daily #News #Today
NASDAQ:VXRTLong
by MyMIWallet
Corona(Covid 19 vaccine) stock that can explode in 2021A little-known biotech is trying its hand at developing a coronavirus vaccine. Can it succeed? over the past year, Vaxart stock has soared over 1,250% because of its spot in the lucrative coronavirus vaccine race. Its stock performance even outpaced those of biotechs that have already brought their coronavirus vaccines to market, such as Moderna and BioNTech. In fact, over 30% of Vaxart stock has been sold short. Vaxart claims to have created an experimental coronavirus vaccine in the form of an oral tablet. One could potentially self-administer the vaccine pill, which is stable at room temperature. This would allow patients to order the vaccine online and have it delivered for at-home use. At the moment, Vaxart's experimental coronavirus vaccine is only in phase 1 clinical trials, with a new data readout expected by next week. Unfortunately, it's impossible to conclude how the experimental vaccine will work on humans from animal models. Hence, the candidate's phase 1 data release will likely be a make-or-break moment for Vaxart. Vaxart is under investigation by both the U.S. Securities and Exchange Commission (SEC) and the Department of Justice (DOJ) for insider trading and inaccurate statements regarding its role in Operation Warp Speed (OWS). Even though Vaxart has more than $133 million in cash and equivalents with no debt whatsoever, that's not nearly enough to move forward. Right now, it could cost billions of dollars to run a potential coronavirus vaccine through clinical trials involving tens of thousands of participants. The company will likely sell more stock to pay for its research and development (R&D) expenses or apply for grant funding -- just to stay afloat. Vaxart is far riskier than the other coronavirus vaccine drugmakers out there. Its corporate conduct is under federal investigation, and its vaccine candidate is in far too early a stage to draw any definitive conclusions about. With a market cap just south of $1 billion, it will undoubtedly become a very undervalued stock if it can bring a coronavirus vaccine to market. Moderna, which has done so, projects $11.7 billion in revenue from its mRNA-1273 vaccine alone. However, the probability of Vaxart achieving anything remotely similar is up for debate. Short-sellers and passionate bulls will be arguing over the stock for the next year. If you believe in Vaxart's science and have the stomach for a roller-coaster ride, then go for it.
NASDAQ:VXRT
by AlenCiken
ORAL PILL VACCINE !!! COVID 19-01/28/2021--------- BULL FLAG ON DAILY 01-29-2021-------BULL FLAG ON HOURLY FEBRUARY 3RD PRESENTATION ON CONFERENCE WITH DR. FAUCI AND OTHER LEGENDS ORAL VACCINE ------ COVID 19 PILL VACCINE ----- NOROVIRUS ----- FLU---- JNJ COLLABORATION---- NEXT WEEK IF FOLLOWED THE TREND AND NEWS are POSITIVE --- $16 IS EASY !!! IF FALL DOWN --- WILL GO TO $10.45 AND STAY THERE TILL ANOTHER DIRECTION! POSSIBLE SHORT SQUEEZE IF IT HITS $16, 33.97 MILLION SHORT AVAILABLE.. ONE OF THE MOST SHORTED TICKER IN 2020.
NASDAQ:VXRTLong
by Hope_Best
4
Inverse Head and ShouldersEarnings Estimated on 12-11 BMO.. Possible stop Inverse Head and shoulders patterns are reliable as a rule.. Head is at 3.50.. LS is 4.5.. RS is 5.28.. Some prefer the RS to be higher than the LS as they say a better outcome is acheived This is not to long entry level and the neckline is resistance until price is above it, then the neckline becomes support.. Not a recommendation.. Inverse H&S pattern completes when the asset's price rallies above the pattern's neckline, or breaks through the resistance line. You can place a stop-loss order (trade stop at a set point) just below the low point of the right shoulder. The take profit level is calculated by measuring the distance between the head and the neckline of the pattern, and then placing the target the same distance from the neckline in the direction of the breakout.
NASDAQ:VXRTLong
by lauralea
1